Let's Talk

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Opt-in
This field is hidden when viewing the form
This field is hidden when viewing the form

CMIC CMO USA Announced New $7 Million Pharmaceutical Manufacturing Line in Cranbury

September 25, 2026

CMIC CMO USA celebrated the inauguration of a new pharmaceutical manufacturing line at its Cranbury facility. The event featured remarks from company and regional leaders, including senior executives visiting from Tokyo, followed by a ceremonial ribbon-cutting and facility tour.

The new line represents a $7 million investment and expands CMIC’s capacity to support pharmaceutical products from development through commercial production. The project reflects the company’s continued growth in New Jersey, where it has operated for more than two decades.

CMIC CMO USA is a U.S.-based contract development and manufacturing organization providing pharmaceutical development and manufacturing services. Its 270,000-square-foot Cranbury facility supports oral solid dosage forms, continuous tablet manufacturing, controlled substances, and other pharmaceutical platforms.

Start typing and press enter to search

Scroll to Top